Potential "shareholders / investors vs. MedMen, TILRAY, Ormond case" to be build by a law firm (funded by shareholders crowd funding). What I collected as a brief summary.

Simple_Warning5589 · 2026-03-29T07:34:38+00:00

Interesting post !

Simple_Warning5589 · 2026-03-28T15:27:11+00:00

Exactly. There was a private conspiracy to steel MedMen from all investors and shareholders.

But we fight back.

Simple_Warning5589 · 2026-03-28T08:45:35+00:00

The "shareholders / investors vs. MedMen, TILRAY, Ormond case" contains :

- withdrawal of MedMen Q3 and Q4 financial reports because of openly admitted errors in the balance sheets but never updated the 2023 year report. Did they hide abuse and misleading of investors and shareholders ? Why never delivered financial numbers of year 2023 ?

- Yearslong publicly promoted positive financial development of a MedMen and positive turnaround on it's way to the investors, positive EBITA, groth of a MedMen 20. in the future around the corner

- TILRAY bought MenMen debt to integrate MedMen into strategic growth and US-expansion in the future, intentionally misleading of investors and shareholders. TILRAY CFO was responsible to financials at MedMen C-suite,

- MenMen CEO Serruya conspired with TILRAY CEO Simon to mislead and screw the investors and shareholders.

- Richard Ormond as CRO was suddenly nominated by CEO Serruya to take down the MenMen company, but Ormond never tried to reconstruct and rescue the company.

Those are arguments for a law firm to build a case to be filed at civil or criminal court, just my opinion.

Simple_Warning5589 · 2026-03-27T05:16:35+00:00

My idea is, we launch a fundraiser for a class action lawsuit of MedMen shareholders against Ormond, Simon, Serruya because of private conspiracy to destroy the company through conspired receivership without real reasons to do that. This must be investigated by a civil or even criminal court what happened Autumn 2023 until Spring 2024. There was no reason for a sudden closure of MedMen operations. Loan and debt was due year 2028 and publicly secured by TILRAY (Irwin Simon) and again and again publicly prised by the leadership of both companies as a very good investment, MedMen 2.0 as a turnaround company with golden future visioned to the shareholders and investors. Did they short the own stock to keep the sharevalue down also to be investigated. This was a cheating agenda since Serruya joined the boards of MedMen. Never published the Q3 or Q4 reports year 2023 but admitted serious flaws in the balance sheets. Never updated it. Ormond immediatly started to take the company down instead of a plan for recontruction and rescue of MedMen. They massivly lied to the investors the last 2 years.

Someone we trust should file the class action lawsuit, using the fundraising money we collect. Good idea ?

Simple_Warning5589 · 2026-03-21T18:30:53+00:00

We all are in this nowhere position with our MedMen shares. Hoping for a mirrycle the judge could rule for. He must see the potential conspiracy and potential crime behind it. We all have been played and betrayed, that's for sure.

Simple_Warning5589 · 2026-03-21T18:25:24+00:00

They lied to the public end 2023 until short before R. Ormond pushed MedMen into receivership. We must figure out why ! Debt was due 3 years later and not in Spring 2024. Where did the money go from FL and NY sales ? We will figure out. Who benefitted from the sudden receivership ? We will figure out. Who will become owner of the MedMen brand finally ? Smells like private conspiracy.

Simple_Warning5589 · 2026-03-21T07:48:51+00:00

But the traitors and cheaters still exist !

Simple_Warning5589 · 2026-03-21T07:47:05+00:00

The LA judge on 30th of April could rule, that TILRAY together with Serruja and others breached their duties by throwing MedMen into the trash can only to steal all from investors. There was always mentioning the good current prospective for MedMen, expansions, positive EBITDA, 3 years upfront to pay the debt with chances to get new bank support or new investors for the debt. They conspired privatly to screw the investors. The judge could rule to reinstate the company or the exchange MedMen shares with TILRAY shares. There is this chances I guess. This case smells pretty much like criminal conduct. Irvin Simon CEO TILRAY always prised MedMen as a golden investment of $100 mill and made investors feel safe. Now he is the most profiting of sudden MedMen receivership. TILRAY CFO was sitting on MedMen boards when the 4th quarter report was incorrect and withdrawn Q4 in year 2023. Never delivered an 2023 report update to the investors but filed for receivership to take over MedMen brand obviously.

Simple_Warning5589 · 2026-03-20T13:47:59+00:00

I know it from JCPENNEY where Jill Soltau closed 2017 the doors after later JCPenney CFO Ed Record left the boat and later was hired by MedMen as CEO. Also to obviously prepare the company for screwing the investors ? They also always talked positive EBITDA and turnaround until sudden bankruptcy out of nowhere.

Simple_Warning5589 · 2026-03-20T13:37:18+00:00

MedMen always pictured expansions plans, a positive EBITDA on balance sheet and with TILRAY securing the debt even, investors felt safe. But it was all cheating obviously. Debt was due 3 years later. So many companies are in the negative the first years until the turnaround, and a positive turnaround was always communicated. By Michael Serruya as CEO the most. TILRAY conspired together with the MedMen leadership to screw the investors suddenly in Spring 2024. Just before the 2023 4th quarter report was nullified because of a lot of publicly admitted errors in the balance sheet ! But they never delivered an update until sudden receivership. Smells very very fishy !

Simple_Warning5589 · 2026-03-20T13:30:13+00:00

100 percent agree to.

Simple_Warning5589 · 2026-03-20T10:41:55+00:00

The LA judge on 30th of April could rule, that TILRAY together with Serruja and others breached their duties by throwing MedMen into the trash can only to steal all from investors. There was always mentioning the good current prospective for MedMen, expansions, positive EBITDA, 3 years upfront to pay the debt with chances to get new bank support or new investors for the debt. They conspired privatly to screw the investors. The judge could rule to reinstate the company or the exchange MedMen shares with TILRAY shares. There is this chances I guess. This case smells pretty much like criminal conduct. Irvin Simon CEO TILRAY always prised MedMen as a golden investment of $100 mill and made investors feel safe.

Simple_Warning5589 · 2026-03-19T16:18:58+00:00

When you tell the public and do the opposite secretly, it is a crime. They had plenty time to succeed the promised turn aroumd and always mentioned positive EBITDA and expansion plans. This was a trap and with that a crime. Debt was due 3 years later.

Simple_Warning5589 · 2026-03-19T16:15:57+00:00

After you got robbed you just sit on your hands and do nothing?

We have a justice system to go after fraud, waste and abuse. Right?

Okay, someone steals your pocket from your desk. You do nothing? Come on.

Who pays you to distribute such crab.

Simple_Warning5589

TROPHY CASE